Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osheroff

Showing results (161-170 of 362) with videos related to

Pageof 37
Sort By:
The Journal of Biological Chemistry|February 25, 1980
Electrostatic interactions in cytochrome c. The role of interactions between residues 13 and 90 and residues 79 and 47 in stabilizing the heme crevice structureN Osheroff, D Borden, W H Koppenol, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1995
Is intercompartmental urea clearance during hemodialysis a perfusion term? A comparison of two pool urea kinetic modelsD Schneditz, B Fariyike, R Osheroff, et al.
Clinical Immunology and Immunopathology|February 1, 1984
Monoclonal antibodies to a recombinant human leukocyte interferon (rIFN-alpha B)P L Osheroff, S M Tahara, T R Chiang
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 24, 1999
Renal disease in the managed care setting: selection and monitoring of outcome criteriaR Hannah, N W Levin, R London, et al.
The Journal of Biological Chemistry|September 1, 1995
A mutation in yeast TOP2 homologous to a quinolone-resistant mutation in bacteria. Mutation of the amino acid homologous to Ser83 of Escherichia coli gyrA alters sensitivity to eukaryotic topoisomerase inhibitorsY Hsiung, S H Elsea, N Osheroff, et al.
The Journal of Biological Chemistry|September 25, 1978
Definitaion of cytochrome c binding domains by chemical modification. Reaction of carboxydinitrophenyl- and trinitrophenyl-cytochromes c with baker's yeast cytochrome c peroxidaseC H Kang, D L Brautigan, N Osheroff, et al.
ACS Infectious Diseases|July 31, 2024
Interactions between Zoliflodacin and <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enzymological Basis for Cellular TargetingJessica A Collins, Gregory S Basarab, Kelly Chibale, et al.
Journal of Healthcare Information Management : JHIM|February 16, 2007
A review of methods to estimate the benefits of electronic medical records in hospitals and the need for a national benefits databaseDouglas I Thompson, Jerry Osheroff, David Classen, et al.
The Journal of Biological Chemistry|March 20, 2013
Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIαYeonee Seol, Amanda C Gentry, Neil Osheroff, et al.
The Journal of Biological Chemistry|January 27, 1995
A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticineS H Elsea, Y Hsiung, J L Nitiss, et al.
Pageof 37

Showing results (161-170 of 362) with videos related to

Sort By:
Pageof 37
The Journal of Biological Chemistry|February 25, 1980
Electrostatic interactions in cytochrome c. The role of interactions between residues 13 and 90 and residues 79 and 47 in stabilizing the heme crevice structureN Osheroff, D Borden, W H Koppenol, et al.
Journal of the American Society of Nephrology : JASN|November 1, 1995
Is intercompartmental urea clearance during hemodialysis a perfusion term? A comparison of two pool urea kinetic modelsD Schneditz, B Fariyike, R Osheroff, et al.
Clinical Immunology and Immunopathology|February 1, 1984
Monoclonal antibodies to a recombinant human leukocyte interferon (rIFN-alpha B)P L Osheroff, S M Tahara, T R Chiang
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 24, 1999
Renal disease in the managed care setting: selection and monitoring of outcome criteriaR Hannah, N W Levin, R London, et al.
The Journal of Biological Chemistry|September 1, 1995
A mutation in yeast TOP2 homologous to a quinolone-resistant mutation in bacteria. Mutation of the amino acid homologous to Ser83 of Escherichia coli gyrA alters sensitivity to eukaryotic topoisomerase inhibitorsY Hsiung, S H Elsea, N Osheroff, et al.
The Journal of Biological Chemistry|September 25, 1978
Definitaion of cytochrome c binding domains by chemical modification. Reaction of carboxydinitrophenyl- and trinitrophenyl-cytochromes c with baker's yeast cytochrome c peroxidaseC H Kang, D L Brautigan, N Osheroff, et al.
ACS Infectious Diseases|July 31, 2024
Interactions between Zoliflodacin and <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enzymological Basis for Cellular TargetingJessica A Collins, Gregory S Basarab, Kelly Chibale, et al.
Journal of Healthcare Information Management : JHIM|February 16, 2007
A review of methods to estimate the benefits of electronic medical records in hospitals and the need for a national benefits databaseDouglas I Thompson, Jerry Osheroff, David Classen, et al.
The Journal of Biological Chemistry|March 20, 2013
Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIαYeonee Seol, Amanda C Gentry, Neil Osheroff, et al.
The Journal of Biological Chemistry|January 27, 1995
A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticineS H Elsea, Y Hsiung, J L Nitiss, et al.
Pageof 37